Men and women across the world are at a high risk for cancer, but certain cancers disproportionately affect women. These discrepancies are often attributed to anatomical variations, among other factors. In the United States, cancer ranks as the second leading cause of death, surpassed only by heart disease, with staggering statistics showing that 1 in 4 American women succumb to cancer.
Given the profound impact of cancer, raising awareness is paramount. To shed light on the most prevalent cancer-related fatalities among women in the U.S., let’s delve into the top three culprits.
Topping the list is lung and bronchus cancer, claiming over 61,000 female lives annually. While not the most commonly diagnosed, it reigns as the deadliest. Cigarette smoke stands as the primary culprit, closely followed by radon gas and secondhand smoke. However, worsening air quality, coupled with exposure to hazardous chemicals and environmental pollutants, exacerbates the incidence rates. Encouragingly, declining smoking rates and advancements in treating non-small cell lung cancer have contributed to a reduction in mortality rates.
Next in line is breast cancer, responsible for approximately 43,250 deaths each year. Ranking as the second most prevalent cancer among American women after skin cancer, breast cancer’s risk escalates with age. Various factors, including family history, weight, reproductive history, and lifestyle choices, influence susceptibility. While prevention remains elusive, routine screenings such as self-exams, mammograms, and annual healthcare provider evaluations are pivotal in early detection and intervention.
Finally, colon and rectum cancer, or colorectal cancer (CRC), emerges as the third leading cause of female cancer-related deaths, claiming more than 24,180 lives annually in the U.S. This malignancy affects both large and small intestines, including the rectum. Risk factors encompass age, family history, presence of polyps, and certain chronic intestinal conditions. Lifestyle factors like smoking, excessive alcohol consumption, and dietary habits further elevate risk levels. Regular CRC screening, typically commencing in one’s 40s, aids in early detection and treatment planning.
Amidst these sobering statistics, advancements in medical science offer hope. Kidney cancer genetic testing is among the innovative approaches that hold promise in identifying predispositions and guiding personalized preventive measures and treatments.
In the quest to combat cancer, knowledge is power. To delve deeper into the most prevalent cancers affecting women and explore cutting-edge insights, refer to the accompanying resource from Natera. Together, let’s empower women with information and support in the fight against cancer.
